| BIOMARIN PHAR. DL-,001 | 68,72 / -0,10% |
| 日期/時間 | 19.01. / 15:00 |
| 漲跌。 / 漲跌。(%) | -0,07 / -0,10% |
| Bid | 68,48 / 300 |
| Ask | 68,69 / 300 |
| 打開 | 69,23 |
| 過往收市 | 68,79 |
| 高 | 69,34 |
| 低 | 68,72 |
| 成交量 [EUR] | 0,00 |
| 成交量 [Units] | 0 |
| Price fixings | 13 |
| ISIN | US09061G1013 |
| 符號 | BM8 |
| 交易所 | Düsseldorf |
| 類型 | 股票 |
所有交易
| 交易所 | 最後的 | 成交量 | |
|---|---|---|---|
| NASDAQ | 83,1900 |  |
125.265 |
| IEX | 84,79 |  |
10.076 |
| Cboe US | 83,19 | |
4.011 |
| Vienna Globa.. | 68,80 | |
296 |
| TradeGate | 69,530 | |
200 |
| Xetra | 69,32 | |
50 |
| Berlin | 69,62 | |
30 |
| Frankfurt | 69,0000 | |
5 |
| München | 69,04 | |
0 |
| Düsseldorf | 68,72 | |
0 |
| Lang & Schwa.. | 68,55 | |
|
| Stuttgart | 68,750 | |
|
| gettex | 68,660 | |
|
| Mexico | 1.599,31 | |
4.200 |
| London Inter.. | 81,84 | 295 |
新聞
- BioMarin sinks 32% as FDA delays its hemophilia treatment
19.08.2020 / 16:23 - TeleTrader - Nasdaq turns red as pharma stocks fall
28.04.2020 / 16:48 - TeleTrader - BioMarin Enrolls First Participant in Phase 3 Trial of Vosoritide for Treatment of Children with Achondroplasia
12.12.2016 / 14:29 - GlobeNewswire - NICE Recommends BioMarin's Vimizim® (elosulfase alfa) for the Treatment of Morquio A Syndrome in England
23.11.2015 / 16:59 - GlobeNewswire